<DOC>
	<DOCNO>NCT01522586</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , pharmacokinetics pharmacodynamics orally administrate DWP09031 healthy male volunteer .</brief_summary>
	<brief_title>Clinical Trial Investigate Safety , Tolerability , Pharmacokinetics DWP09031</brief_title>
	<detailed_description />
	<criteria>1 . Healthy adult male subject age 20 45 year 2 . The subject Broca 's index ≤ 20 % 3 . A Subject judge healthy investigator participate study base screen result ( accord standard reference index update recently ) 4 . A subject provide write informed consent participate study cooperative regard compliance study relate constraint 1 . A subject sign symptom previously diagnose disease liver ( viral hepatitis ) , digestive system , cardiovascular , kidney , respiratory , endocrinology , neurology , immune system , hematology , psychology function significant diseases history suspicion current drug abuse alcohol abuse 2 . A subject show vital sign number systolic blood pressure ≥141 mmHg ≤89 mmHg , number diastolic blood pressure ≥91mmHg 3 . A subject show follow result clinical laboratory test : AST , ALT &gt; 1.25 time upper limit normal range PR ≥ 210 msec QRS ≥ 120 msec QT ≥ 500 msec QTcF ≥ 450 msec creatinine clearance ≤ 80mL/min 4 . Subject take clinical licensed medication another clinical trial within 90day period prior first administration study medication ( The last administration medication consider end point previous clinical trial ) .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>